Effects of autologous bone marrow‑derived stem cell mobilization on acute tubular necrosis and cell apoptosis in rats

Bi,Lingyun; Wang,Guohong; Yang,Dasheng; Li,Shujun; Liang,Bin; Han,Ziming

doi:10.3892/etm.2015.2592

Effects of autologous bone marrow‑derived stem cell mobilization on acute tubular necrosis and cell apoptosis in rats

Authors:
- Lingyun Bi
- Guohong Wang
- Dasheng Yang
- Shujun Li
- Bin Liang
- Ziming Han
View Affiliations

Affiliations: Department of Pediatrics, The First Affiliated Hospital of Xinxiang Medical University, Weihui, Henan 453100, P.R. China, Laboratory of Physiology, Xinxiang Medical University, Xinxiang, Henan 453000, P.R. China
Published online on: June 24, 2015 https://doi.org/10.3892/etm.2015.2592
Pages: 851-856
Copyright: © Bi et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of this study was to investigate the effects of stem cell factor (SCF) and granulocyte colony‑stimulating factor (G‑CSF) on bone marrow‑derived stem cell (BMSC) mobilization in rat models of renal ischemia/reperfusion (I/R) injury. In addition, the effects of SCF and G‑CSF on cellular apoptosis were explored in order to determine the protective mechanism of the two factors against renal I/R injury. A unilateral renal I/R injury model was established for the model and treatment groups. The treatment and treatment control groups were subcutaneously injected with SCF (200 µg/kg/day) and G‑CSF (50 µg/kg/day) 24 h after the establishment of the model for five consecutive days. The total number of leukocytes in the peripheral blood and the cellular percentages of cluster of differentiation (CD)34+, renal CD34+ and apoptotic cells were detected. The total number of leukocytes in the peripheral blood and the percentages of CD34+ cells in the treatment and treatment control groups reached maximum levels on the fifth postoperative day and were significantly higher than those in the normal control and model groups. The number of renal CD34+ cells in the treatment group was significantly increased compared with that in the treatment control and model groups. The apoptotic indices (AIs) of the model and treatment groups were higher than those of the normal control and treatment control groups. The AI of the model group was significantly higher than that of the treatment group. In conclusion, the combined application of SCF and G‑CSF can mobilize sufficient numbers of BMSCs and cause cellular ‘homing’ to the injured site, thus inhibiting apoptosis and promoting the repair of renal tubular injury.

View Figures

View References

1	Lu R, Muciño-Bermejo MJ, Armignacco P, et al: Survey of acute kidney injury and related risk factors of mortality in hospitalized patients in a third-level urban hospital of Shangai. Blood Purif. 38:140–148. 2014. View Article : Google Scholar : PubMed/NCBI
2	Ferreyra C, Vargas F, Rodríguez-Gómez I, et al: Preconditioning with triiodothyronine improves the clinical signs and acute tubular necrosis induced by ischemia/reperfusion in rats. PLoS One. 26:e749602013. View Article : Google Scholar
3	Hofmann CL and Fissell WH: Middle-molecule clearance at 20 and 35 ml/kg/h in continuous venovenous hemodiafiltration. Blood Purif. 29:259–263. 2010. View Article : Google Scholar : PubMed/NCBI
4	Jia X, Xie X, Feng G, et al: Bone marrow-derived cells can acquire renal stem cells properties and ameliorate ischemia-reperfusion induced acute renal injury. BMC Nephrol. 13:1052012. View Article : Google Scholar : PubMed/NCBI
5	Barile L, Cerisoli F, Frati G, et al: Bone marrow-derived cells can acquire cardiac stem cells properties in damaged heart. J Cell Mol Med. 15:63–71. 2011. View Article : Google Scholar : PubMed/NCBI
6	Osada T, Watanabe M, Hasuo A, et al: Efficacy of the coadministration of granulocyte colony-stimulating factor and stem cell factor in the activation of intrinsic cells after spinal cord injury in mice. J Neurosurg Spine. 13:516–523. 2010. View Article : Google Scholar : PubMed/NCBI
7	Takami T, Terai S and Sakaida I: Advanced therapies using autologous bone marrow cells for chronic liver disease. Discov Med. 14:7–12. 2012.PubMed/NCBI
8	Shen WY, Li JY, Hong M, et al: Clinical study on high-dose etoposide with granulocyte colony-stimulating factor for mobilization of autologous peripheral blood stem cells in patients with hematologic malignancies. Zhonghua Xue Ye Xue Za Zhi. 33:628–631. 2012.(In Chinese). PubMed/NCBI
9	Kale S, Karihaloo A, Clark PR, Kashgarian M, Krause DS and Cantley LG: Bone marrow stem cells contribute to repair of the ischemically injured renal tubule. J Clin Invest. 112:42–49. 2003. View Article : Google Scholar : PubMed/NCBI
10	Parodi AL: Ethical issue in animal experimentation. Bull Acad Natl Med. 193:1737–1746. 2009.(In French). PubMed/NCBI
11	Supavekin S, Zhang W, Kucherlapati R, Kaskel FJ, Moore LC and Devarajan P: Differential gene expression following early renal ischemia/reperfusion. Kidney Int. 63:1714–1724. 2003. View Article : Google Scholar : PubMed/NCBI
12	Zhang H, Bai H, Yi Z, He X and Mo S: Effect of stem cell factor and granulocyte-macrophage colony-stimulating factor-induced bone marrow stem cell mobilization on recovery from acute tubular necrosis in rats. Ren Fail. 34:350–357. 2012. View Article : Google Scholar : PubMed/NCBI
13	Martino M, Console G, Irrera G, et al: Harvesting peripheral blood progenitor cells from healthy donors: retrospective comparison of filgrastim and lenograstim. J Clin Apher. 20:129–136. 2005. View Article : Google Scholar : PubMed/NCBI
14	Booz GW and Baker KM: Molecular signaling mechanisms controlling growth and function cardiac fibroblasts. Cardiovasc Res. 30:537–543. 1995. View Article : Google Scholar : PubMed/NCBI
15	Fernandes NM, Pinto Pdos S, Lacet TB, et al: APACHE II and ATN-ISS in acute renal failure (ARF) in intensive care unit (ICU) and non-ICU. Rev Assoc Med Bras. 55:434–441. 2009.(In Portugese). View Article : Google Scholar : PubMed/NCBI
16	Clark E, Molnar AO, Joannes-Boyau O, et al: High-volume hemofiltration for septic acute kidney injury: a systematic review and meta-analysis. Crit Care. 18:R72014. View Article : Google Scholar : PubMed/NCBI
17	Liu N, Han G, Cheng J, Huang J and Tian J: Erythropoietin promotes the repair effect of acute kidney injury by bone-marrow mesenchymal stem cells transplantation. Exp Biol Med (Maywood). 238:678–686. 2013. View Article : Google Scholar : PubMed/NCBI
18	Le Blanc K and Pittenger M: Mesenchymal stem cells: progress toward promise. Cytotherapy. 7:36–45. 2005. View Article : Google Scholar : PubMed/NCBI
19	Deng Z, Yang C, Deng H, et al: Effects of GM-CSF on the stem cells mobilization and plasma C-reactive protein levels in patients with acute myocardial infarction. Int J Cardiol. 113:92–96. 2006. View Article : Google Scholar : PubMed/NCBI
20	Banerjee M, Kumar A and Bhonde RR: Reversal of experimental diabetes by multiple bone marrow transplantation. Biochem Biophys Res Commun. 328:318–325. 2005. View Article : Google Scholar : PubMed/NCBI
21	Burt R, Pearce W, Luo K, et al: Hematopoietic stem cell transplantation for cardiac and peripheral vascular disease. Bone Marrow Transplant. 32:Suppl 1. S29–S31. 2003. View Article : Google Scholar : PubMed/NCBI
22	Charbord P: Bone marrow mesenchymal stem cells: historical overview and concepts. Hum Gene Ther. 21:1045–1056. 2010. View Article : Google Scholar : PubMed/NCBI
23	Fu S and Liesveld J: Mobilization of hematopoietic stem cells. Blood Rev. 14:205–218. 2000. View Article : Google Scholar : PubMed/NCBI
24	Wojakowski W and Tendera M: Mobilization of bone marrow-derived progenitor cells in acute coronary syndromes. Folia Histochem Cytobiol. 43:229–232. 2005.PubMed/NCBI
25	Powell TM, Paul JD, Hill JM, et al: Granulocyte colony-stimulating factor mobilizes functional endothelial progenitor cells in patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 25:296–301. 2005. View Article : Google Scholar : PubMed/NCBI
26	Zhang JJ, Yi ZW, Dang XQ, He XJ and Wu XC: Mobilization effects of SCF along with G-CSF on bonemarrow stem cells and endothelial progenitor cells in rats with unilateral ureteral obstruction. Zhongguo Dang Dai Er Ke Za Zhi. 9:144–148. 2007.(In Chinese). PubMed/NCBI
27	Da Silva CA, Reber L and Frossard N: Stem cell factor expression, mast cells and inflammation in asthma. Fundam Clin Pharmacol. 20:21–39. 2006. View Article : Google Scholar : PubMed/NCBI
28	Li B, Berman J, Tang JT and Lin TJ: The early growth response factor-1 is involved in stem cell factor (SCF)-induced interleukin 13 production by mast cells, but is dispensable for SCF-dependent mast cell growth. J Biol Chem. 282:22573–22581. 2007. View Article : Google Scholar : PubMed/NCBI
29	Han JY, Goh RY, Seo SY, et al: Cotransplantation of cord blood hematopoietic stem cells and culture-expanded and GM-CSF-/SCF-transfected mesenchymal stem cells in SCID mice. J Korean Med Sci. 22:242–247. 2007. View Article : Google Scholar : PubMed/NCBI
30	Shi Q, Hodora V, Butler SD, et al: Differential bone marrow stem cell mobilization by G-CSF injection or arterial ligation in baboons. J Cell Mol Med. 13:1896–1906. 2009. View Article : Google Scholar : PubMed/NCBI
31	Lennartsson J, Shivakrupa R and Linnekin D: Synergistic growth of stem cell factor and granulocyte macrophage colony-stimulating factor involves kinase-dependent and -independent contributions from c-Kit. J Biol Chem. 279:44544–44553. 2004. View Article : Google Scholar : PubMed/NCBI
32	Carter BZ, Milella M, Altieri DC and Andreeff M: Cytokine-regulated expression of survivin in myeloid leukemia. Blood. 97:2784–2790. 2001. View Article : Google Scholar : PubMed/NCBI
33	Duarte RF and Franf DA: The synergy between stem cell factor (SCF) and granulocyte colony-stimulating factor (G-CSF): Molecular basis and clinical relevance. Leuk Lymphoma. 43:1179–1187. 2002. View Article : Google Scholar : PubMed/NCBI
34	Czekanska EM, Ralphs JR, Alini M and Stoddart MJ: Enhancing inflammatory and chemotactic signals to regulate bone regeneration. Eur Cell Mater. 28:320–334. 2014.PubMed/NCBI
35	Liu N, Patzak A and Zhang H: CXCR4-overexpressing bone marrow-derived mesenchymal stem cells improve repair of acute kidney injury. Am J Physiol Renal Physiol. 305:F1064–F1073. 2013. View Article : Google Scholar : PubMed/NCBI
36	Zhang W, Zhu C, Wu Y, et al: VEGF and BMP-2 promote bone regeneration by facilitating bone marrow stem cell homing and differentiation. Eur Cell Mater. 27:1–12. 2014. View Article : Google Scholar : PubMed/NCBI
37	Yueyi C, Xiaoguang H, Jingying W, et al: Calvarial defect healing by recruitment of autogenous osteogenic stem cells using locally applied simvastatin. Biomaterials. 34:9373–9380. 2013. View Article : Google Scholar : PubMed/NCBI
38	Illien-Jünger S, Pattappa G, Peroglio M, et al: Homing of mesenchymal stem cells in induced degenerative intervertebral discs in a whole organ culture system. Spine (Phila Pa 1976). 37:1865–1873. 2012. View Article : Google Scholar : PubMed/NCBI
39	Chen QQ, Yan L, Wang CZ, et al: Mesenchymal stem cells alleviate TNBS-induced colitis by modulating inflammatory and autoimmune responses. World J Gastroenterol. 19:4702–4717. 2013. View Article : Google Scholar : PubMed/NCBI
40	Ponte AL, Ribeiro-Fleury T, Chabot V, et al: Granulocyte-colony-stimulating factor stimulation of bone marrow mesenchymal stromal cells promotes CD34⁺ cell migration via a matrix metalloproteinase-2-dependent mechanism. Stem Cells Dev. 21:3162–3172. 2012. View Article : Google Scholar : PubMed/NCBI
41	Geutskens SB, Andrews WD, van Stalborch AM, et al: Control of human hematopoietic stem/progenitor cell migration by the extracellular matrix protein Slit3. Lab Invest. 92:1129–1139. 2012. View Article : Google Scholar : PubMed/NCBI
42	Lin F, Cordes K, Li L, et al: Hematopoietic stem cells contribute to the regeneration of renal tubules after renal ischemia-reperfusion injury in mice. J Am Soc Nephrol. 14:1188–1199. 2003. View Article : Google Scholar : PubMed/NCBI
43	Humphreys BD: Kidney injury, stem cells and regeneration. Curr Opin Nephrol Hypertens. 23:25–31. 2014. View Article : Google Scholar : PubMed/NCBI
44	de Almeida DC, Donizetti-Oliveira C, Barbosa-Costa P, Origassa CS and Câmara NO: In search of mechanisms associated with mesenchymal stem cell-based therapies for acute kidney injury. Clin Biochem Rev. 34:131–144. 2013.PubMed/NCBI
45	Li BC, Liu XF, Zhang Y, Sun LJ, Cui RL and Cheng T: Empirical study of bone marrow stem cells participating in the recovery acute tubular necrosis in mice. Zhonghua Shen Zang Bing Za Zhi. 22:664–668. 2006.(In Chinese).
46	Mahmoud K, Opelz G, Pelzl S, et al: Evaluation of hepatocyte growth factor as a sensitive marker for early detection of acute renal allograft rejection. Transplantation. 83:1035–1040. 2007. View Article : Google Scholar : PubMed/NCBI
47	Grzelak P, Szymczyk K, Strzelczyk J, et al: Perfusion of kidney graft pyramids and cortex in contrast-enhanced ultrasonography in the determination of the cause of delayed graft function. Ann Transplant. 16:48–53. 2011.PubMed/NCBI
48	Juarez JC, Manuia M, Burnett ME, et al: Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling. Proc Natl Acad Sci USA. 105:7147–7152. 2008. View Article : Google Scholar : PubMed/NCBI